Skip to main content

Lexaria Bioscience Corp.

LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001348362

No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in Lexaria Bioscience Corp. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
9
No complete 13F data for Q4 2020
Shares held
318.1K
No complete 13F data for Q4 2020
Total value
$1.78M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 9 institutions
Q1 2021: 9 institutionsQ2 2021: 10 institutionsQ3 2021: 11 institutionsQ4 2021: 13 institutionsQ1 2022: 12 institutionsQ2 2022: 16 institutionsQ3 2022: 16 institutionsQ4 2022: 16 institutionsQ1 2023: 17 institutionsQ2 2023: 14 institutionsQ3 2023: 15 institutionsQ4 2023: 20 institutionsQ1 2024: 25 institutionsQ2 2024: 28 institutionsQ3 2024: 27 institutionsQ4 2024: 25 institutionsQ1 2025: 22 institutionsQ2 2025: 21 institutionsQ3 2025: 25 institutionsQ4 2025: 21 institutionsQ1 2026: 28 institutionsQ2 2026: 31 institutions
Value heldQ1 2021: $1.78M
Q1 2021: $1.78MQ2 2021: $2.93MQ3 2021: $2.83MQ4 2021: $1.85MQ1 2022: $1.41MQ2 2022: $1.67MQ3 2022: $1.68MQ4 2022: $1.71MQ1 2023: $1.85MQ2 2023: $651.4KQ3 2023: $1.77MQ4 2023: $1.49MQ1 2024: $3.23MQ2 2024: $5.72MQ3 2024: $3.25MQ4 2024: $3.03MQ1 2025: $2.12MQ2 2025: $2.00MQ3 2025: $1.63MQ4 2025: $1.05MQ1 2026: $1.17MQ2 2026: $920.0K
Institutions holding LEXX and their total value by quarter
QuarterHoldersValue
Q2 202631$920.0K
Q1 202628$1.17M
Q4 202521$1.05M
Q3 202525$1.63M
Q2 202521$2.00M
Q1 202522$2.12M
Q4 202425$3.03M
Q3 202427$3.25M
Q2 202428$5.72M
Q1 202425$3.23M
Q4 202320$1.49M
Q3 202315$1.77M
Q2 202314$651.4K
Q1 202317$1.85M
Q4 202216$1.71M
Q3 202216$1.68M
Q2 202216$1.67M
Q1 202212$1.41M
Q4 202113$1.85M
Q3 202111$2.83M
Q2 202110$2.93M
Q1 20219$1.78M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding LEXX in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Invenomic Capital Management LP296,101$1.66M0.80%––
Citadel Advisors LLC14,915$84.0K0.00%––
Edge Wealth Management LLC3,333$19.0K0.00%––
MD Financial Management Inc.2,686$15.0K0.00%––
Royal Bank of Canada705$4.00K0.00%––
Bank of America Corp145$1.00K0.00%––
Advisor Group Holdings, Inc.166$1.00K0.00%––
Wells Fargo & Company29$00.00%––
Bank of Montreal33$00.00%––